Phase 4, Open-label Study to Evaluate Treatment Satisfaction With Erenumab in Patients With Migraine
Phase 4, Open-label Study to Evaluate Treatment Satisfaction With Erenumab in Patients With Migraine
The main purpose of this study is to evaluate the effect of erenumab on medication-specific treatment satisfaction.
Inclusion Criteria:
Exclusion Criteria:
Great Neck, New York 11021, United States
Poughkeepsie, New York 12601, United States